Molecular epidemiology of hematological neoplasms - present status and future directions

Leukemia Research

Volumn 21, Issue 4, 1997, Pages 265-284

  Shpilberg, Ofer ^a,b   Dorman, Janice S ^c   Shahar, Avner ^c   Kuller, Lewis H ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c NONE

Author keywords

Environmental exposure; Genetic predisposition; Hematologic neoplasms; Molecular epidemiology

Indexed keywords

MUTAGENIC AGENT;

CANCER EPIDEMIOLOGY; CANCER GENETICS; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CYTOGENETICS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HUMAN; LEUKEMIA; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ANIMALS; ENVIRONMENTAL EXPOSURE; FORECASTING; HEMATOLOGIC NEOPLASMS; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030951136     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00093-8     Document Type: Review

References (167)

1. Shimizu Y., Kato H. & Schll W. J. Studies of the mortality of A-bomb survivors. Radiation Research, 1990, 121, 120.
2. Aksoy M. Malignancies due to occupational exposure to benzene. American Journal of Industrial Medicine, 1985, 7, 395.
3. Askoy M. Benzene as a leukemogenic and carcinogenic agent. American Journal of Industrial Medicine, 1985, 8, 9.
4. Heim S. & Mitelman F. Acute nonlymphocytic leukemia. In Cancer Cytogenetics, 1987, pp. 65-110. Alan R. Liss, New York.
5. Adamson J. W., Fialkow P. J. & Murphy S. Polycythemia vera: stem-cell and probable clonal origin of the disease. New England Journal of Medicine, 1976, 295, 913.
6. Fialkow P. J., Jacobson R. J. & Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. American Journal of Medicine, 1977, 63, 125.
7. Epstein J., Xiao H. & He X. Y. Markers of multiple hematopoietic-cell lineage in multiple myeloma. New England Journal of Medicine, 1990, 322, 664.
8. Haase D., Feuring-Buske M., Konemann S., Fonatsch C., Troff C., Verbeek W., Pekrun A., Hiddemann W. & Wormann B. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood, 1995, 86, 2906.
9. Cline M. J. The molecular basis of leukemia. New England Journal of Medicine, 1994, 330, 328.
10. Miller B. A. Ries L. A. G., Hankey B. F., Kosary C. L., Harras A. Devesa S. & Edwards B. K. (Eds) SEER Cancer Statistics Review: 1973-1990. National Cancer Institute. NIH Pub. No. 93-2789, 1993.
11. Higginson J. & Muir C. S. The role of epidemiology in elucidating the importance of environmental factors in human cancer. Cancer Detection and Prevention, 1976,1, 79.
12. Jones P. A., Buckley J. D., Henderson B. E., ROSS R. K. & Pike M. C. From gene to carcinogen: A rapidly evolving field in molecular epidemiology. Cancer Research, 1991, 51, 3617.
13. Perera F. P. & Weinstein I. B. Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to studies of human cancer causation. Journal of Chronic Diseases, 1982, 35, 581.
14. Dorman J. S. on behalf of the international Molecular Epidemiology Task Force In Standardization of Epidemiologic Studies of Host Susceptibility (Dorman Journal of S., Ed.), 1994. New York, Plenum Press.
15. Hulka B. S., Wilcosky T. C. & Griffith J. D. Biological Markers in Epidemiology. Oxford University Press, New York, 1990.
16. Hulka B. S. Epidemiological studies using biological markers: Issues for epidemiologists. Cancer Epidemiological Biomarkers Preview, 1991, 1, 13.
17. Taylor J. A. Oncogenes and their applications in epidemiologic studies. American Journal of Epidemiology, 1989, 130, 6.
18. Easton D. F. The inherited component of cancer. British Medical Bulletin, 1994, 50, 527.
19. Li F. P. Phenotypes, genotypes, and interventions for hereditary cancers. Cancer Epidemiological Biomarkers Preview, 1995, 4, 579.
20. Shields P. G. & Harris C. C. Molecular epidemiology and the genetics of environmental cancer. Journal of American Medical Association, 1991, 266, 681.
21. Dorman J. S., LaPorte R. E., Stone R. A. & Trucco M. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ β chain. Proceedings of the National Academy of Sciences U.S.A., 1990, 87, 7370.
22. Khoury M. J. Flanders W. D., Lipton R. B. & Dorman J. S. The affected sib-pair method in the context of an epidemiologic study design. Genetics and Epidemiology, 1991, 8, 277.
23. Mack T. M., Cozen W., Shibata D. K., Weiss L. M., Nathwani B. N., Hernandez A. M., Taylor C. R., Hamilton A. S., Deapen D. M. & Rappaport E. B. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. New England Journal of Medicine, 1995, 332, 413.
24. Dameshek W., Savitz H. A. & Arbor B. Chronic lymphatic leukemia in twin brothers aged fifty-six. Journal of the American Medical Association, 1929, 92, 1348.
25. Fraumeni J. F. Jr, Vogel C. L. & DeVita V. T. Familial chronic lymphocytic leukemia. Annals of Internal Medicine, 1969, 71, 279.
26. Grufferman S., Cole P., Smith P. G. & Lukes R. J. Hodgkin's disease in siblings. New England Journal of Medicine, 1977, 926, 248.
27. Haim N., Cohen Y. & Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer, 1982, 49, 2197.
28. Shoenfeld Y., Berliner S., Shaklai M., Gallant L. A. & Pinkhas J. Familial multiple myeloma. A review of thirty-seven families. Postgraduate Medical Journal, 1982, 58, 12.
29. Brubaker L. H., Wasserman L. R., Goldberg J. D., Pisciotta A. V., McIntyre O. R., Kaplan M. E., Modan B., Flannery J. & Harp R. Increased prevalence of polycythemia vera in parents of patients on polycythemia vera study group protocols. American Journal of Hematology, 1984, 16, 367.
30. Siebert R., Jhanwar S., Brown K., Berman E. & Offit K. Familial acute myeloid leukemia and DiGuglielmo syndrome. Leukemia, 1995, 9, 1091.
31. McPhedran P., Heath C. W. & Lee J. Patterns of familial leukaemia: Ten cases of leukaemia in two interrelated families. Cancer, 1969, 24, 403.
32. Snyder A. L., Henderson E. S., Li F. P. & Todaro G. J. Possible inherited leukaemogenic factors in familial acute myelogenous leukaemia. Lancet, 1970, i, 586.
33. Kaur J., Catovsky D., Valdimarsson H., Jensson O. & Spiers A. S. D. Familial acute myeloid leukaemia with acquired Pelger-Huet anomaly and aneuploidy of C group. British Medical Journal, 1972, 4, 327.
34. Eriksson M. & Bergstrom I. Familial malignant blood disease in the county of Jamtland Sweden. European Journal of Haematology, 1987, 38, 241.
35. Linet M. S., Van Natta M. L., Brookmeyer R., Khoury M. J., McCaffrey L. D., Humphrey R. L. & Szklo M. Familial cancer history and chronic lymphocytic leukemia A case-control study. American Journal of Epidemiology, 1989, 130, 655.
36. Eriksson M. & Hallberg B. Familial occurance of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes and Control, 1992, 3, 63.
37. Shpilberg O., Modan M, Modan B., Chetrit A., Fuchs Z. & Ramot B. Familial aggregation of haematological neoplasms: a controlled study. British Journal of Haematology, 1994, 87, 75.
38. Shpilberg O., Modan M., Modan B., Chetrit A. & Ramot B. Lack of evidence for familial aggregation of non-hematological neoplasms in relatives of patients with hematological neoplastic disorders. Genetics and Epidemiology, 1995, 12, 335 (Abst. 62).
39. Goldgar D. E., Easton D. F., Cannon-Albright L. A. & Skolnick M. H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute, 1994, 86, 1600.
40. Linet M. S. & Pottern L. M. Familial aggregation of hematopoietic malignancies and risk of non-Hodgkin's lymphoma. Cancer Research, 1992, 52, 5468s.
41. Douer D., Preston-Martin S., Chang E., Nichols P. W., Watkins K. J. & Levine A. M. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood, 1996, 87, 308.
42. Mele A., Stazi M. A., Pulsoni A., Visani G., Monarca B., Castelli G., Rocchi L., Avvisati G. & Mandelli F. Epidemiology of acute promyelocytic leukemia. Haematologica, 1995, 80, 405.
43. Avvisati G., Mele A., Stazi M. A., Vegna M. L., Pasquini P. & Mandelli F. Epidemiology of acute promyelocytic leukemia in Italy. Annals of Oncology, 1991, 2, 405.
44. Prokocimer M. & Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: Projection on the hematologic cell lineages. Blood, 1994, 84, 2391.
45. Li F. P. & Fraumeni J. F. Jr Soft-tissue sarcomas, breast cancer, and other neoplasms A familial syndrome? Annals of Internal Medicine, 1969, 71, 747.
46. Li F. P., Fraumeni J. F. Jr, Mulvihill J. J., Blattner W. A., Dreyfus M. G., Tucker M. A. & Miller R. W. A cancer family syndrome in twenty-four kindreds. Cancer Research, 1988, 48, 5358.
47. Malkin D., Li F. P., Strong L. C., Fraumeni J. F. Jr, Nelson C. E., Kim D. H., Kassel J., Gryka M. A., Bischoff F. Z., Tainsky M. & Friend S. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms (Washington DC). Science, 1990, 250, 1233.
48. Greenblatt M. S., Bennett W. P., Hollstein M. & Harris C. C. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Research, 1994, 54, 4855.
49. Felix C. A., D'Amico D., Mitsudomi T., Nau M. M., Li F. P., Fraumeni J. F., Cole D. E., McCalla J., Reaman G. H., Whang-Peng J., Knutsen T., Minna J. D. & Poplack D. G. Absence of hereditary p53 mutations in 10 familial leukemia pedigrees. Journal of Clinical Investigation, 1992, 90, 653.
50. Racevskis J., Wiernik P. H., Kirshner E. D., Raghavan V. & Paietta E. Absence of hereditary p53 mutations in eight familial Hodgkin's disease pedigrees. Leukemia, 1995, 9, 1966.
51. Lin A., Dale J., Fleisher T., Fisher G., Rosenberg F., Lenardo M., Puck J., Middelton L., Corden B., Tucker M. & Straus S. Familial aggregation of Hodgkin's disease, autoimmune lymphoproliferative syndrome and germline Fas mutations. Blood, 1995, 86, 271a (abstr 1072, suppl. 1).
52. Boman B. M. Biologic functions of the genes responsible for familial cancer. Current Opinions in Oncology, 1994, 6,90.
53. Zhu Y. M., Haynes A. P., Keith F. J. & Russell N. H. Abnormalities of retinoblastoma gene expression in hematological malignancies. Leukemia and Lymphoma, 1995, 18, 61.
54. Kornblau S. M., Xu H. J., Giglio A. D., Hu S. X., Zhang W., Calvert L., Beran M., Estey E., Andreeff M., Trujillo J., Cork M. A., Smith T. L., Benedict W. F. & Deisseroth A. B. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Research, 1992, 52, 4587.
55. Kornblau S. M., Xu H. J., Zhang W., Hu S. X., Beran M., Smith T. L., Hester J., Estey E., Benetict W. F. & Deisseroth A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 1994, 84, 256.
56. Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Bocadoro M., Pileri A. & Dalla-Favera R. Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia, 1994, 8, 758.
57. Shpilberg O., Dorman J. S., Ferrell R. E., Trucco M., Shahar A. & Kuller L. H. The next stage. Molecular Epidemiology, (submitted).
58. Morrell D., Cromartie E. & Swift M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. Journal of the National Cancer Institute, 1986, 77, 89.
59. Steingrimsdottir H., Rowley G., Waugh A., Beare D., Ceccherini I., Cole J. & Lehmann A. R. Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors. Mutation Research, 1993, 294, 29.
60. Kirsch I. R. V(D)J recombination and ataxia-telangiectasia: a review. Internal Journal of Radiation Biology, 1994, 66 (Suppl.) 97s.
61. Narducci M. G., Virgilio L., Isobe M., Stoppaacciaro A., Elli R., Fiorilli M., Carbonari M., Antonelli A., Chessa L., Croce C. M. & Russo G. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood, 1995, 86, 2358.
62. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S. R., Simmons A., Clines G. A., Sartiel A., Gatti R., Chessa L., Sanal O., Lavin M. F., Jaspers N. G. J., Taylor M. R., Arlett C. F., Miki T., Weissman S. M., Lovett M., Collins F. S. & Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science, 1995 268, 1749.
63. Lehmann A. R. & Carr A. M. The ataxia-telangiectasia gene: a link between checkpoint controls, neurodegeneration and cancer. TIG, 1995, 11, 375.
64. Ellis N. A., Groden J., Ye T. Z., Straughen J., Lennon D. J., Ciocci S., Proytcheva M. & German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell, 1995, 83, 655.
65. Butturini A., Gale R. P., Verlander P. C., Adler-Brecher B., Gillio A. P. & Auerbach A. D. Hematologic abnormalities in Fanconi anemia: an international Fanconi anemia registry study. Blood, 1994, 84, 1650.
66. Speicher M. R. Microsatellite instability in human cancer. Oncology Research, 1995, 7, 267.
67. Robledo M., Martinez B., Arranz E., Trujillo M. J., Gonzalez Ageitos A. G., Rivas C. & Benitez J. Genetic instability of microsatellites in hematological neoplasms. Leukemia, 1995, 9, 960.
68. Honchel R., Hailing K. C., Schaid D. J., Pittelkow M. & Thibodeau S. N. Microsatellite instability in Muir-Torre syndrome. Cancer Research, 1994, 54, 1159.
69. Gartenhaus R., Johns III M. M., Wang P., Rai K. & Sidransky D. Mutator phenotype in a subset of chronic lymphocytic leukemia. Blood, 1996, 87, 38.
70. Reitamir A. H., Schmits R., Ewel A., Bapat B., Redston M., Mitri A., Waterhouse P., Mittrucker H. W., Wakeham A., Liu B., Thomason A., Griesser H., Gallinger S., Ballhausen W. G., Fishel R. & Mak T. W. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nature Genetics, 1995, 11, 64.
71. Olden K. Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis. Journal of the National Cancer Institute, 1994, 86, 1660.
72. Ottman R. An epidemiologic approach to gene-environment interaction. Genetics and Epidemiology, 1990, 7, 177.
73. Nakachi K., Imai K., Hayashi S. & Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 1993, 53, 2994.
74. Warwick A. P., Redman C. W. E., Jones P. W., Fryer A. A., Gilford J., Alldersea J. & Strange R. C. Progression of cervical intraepithelial neoplasia to cervical cancer: interactions of cytochrome P450 CYP2D6 EM and glutathione S-transferase GSTM1 null genotypes and cigarette smoking. British Journal of Cancer, 1994, 70, 704.
75. Wolf C. R., Smith C. A. D., Gough A. C., Moss J. E., Vallis K. A., Howard G., Carey F. J., Mills K., McNee W., Carmichael J. & Spurr N. K. Relationship between the debrisoquine polymorphism and cancer susceptibility. Carcinogenesis, 1992, 13, 1035.
76. Chen H., Sandler D. P., Taylor J. A., Shore D. L., Liu E., Bloomfield C. D. & Bell D. A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet, 1996, 347, 295.
77. Morrow C. S. & Cowan K. H. Glutathione S transferase and drug resistance. Cancer Cells, 1990, 2, 15.
78. Russo D., Marie J. P., Zhou D. C., Faussat A. M., Melli C., Damiani D., Michelutti A., Michieli M., Fanin R., Baccarani M. & Zittoun R. Evaluation of the clinical relevance of the anionic glutathione-S-transferase (GSTπ) and multidrug resistance (mdr-1) gene coexpression in leukemias and lymphomas. Leukemia and Lymphoma, 1994, 15, 453.
79. Fong C. & Brodeur G. M. Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genetics and Cytogenetics, 1987, 28, 55.
80. Zipursky A., Poon A. & Doyle J. Leukemia in Down syndrome: a review. Pediatrics, Hematology, Oncology, 1992, 9, 139.
81. Rowley J. D. Down syndrome and acute leukaemia: increased risk may be due to trisomy 21. Lancet, 1981, 2, 1020.
82. Sacchi N. A. Down syndrome and chromosome 21 abnormalities in leukaemia. Bailliere's Clinical Haematology, 1992, 5, 815.
83. Korenberg J. R., Chen X. N., Schipper R., Sun Z., Gonsky R., Gerwehr S., Carpenter N., Daumer C., Dignan P., Disteche C., Graham J. M. Jr, Hugdins L., McGillivary B., Miyazaki K., Ogasawara N., Park J. P., Pagon R., Pueschel S., Sack G., Say B., Schuffenhauer S., Soukup S. & Yamanaka T. Down syndrome phenotypes: The consequences of chromosomal imbalance. Proceedings of the National Academy of Sciences, U.S.A., 1994,91,4997.
84. Erickson P., Gao J., Chang K. S., Look T., Whisenant E., Raimondi S., Lasher R., Trujillo J., Rowley J. & Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood, 1992, 80, 1825.
85. Perry G. S. III, Spector B. D., Schuman L. M., Mandel J. S., Anderson V. E., McHugh R. B., Hanson M. R., Fahlstrom S. M., Krivit W. & Kersey J. H. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979). Journal of Pediatrics, 1980, 97, 72.
86. Cunningham-Rundles C., Siegal F. P., Cunningham-Rundles S. & Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. Journal of Clinical Immunology, 1987, 7, 294.
87. Rosen F. S., Cooper M. D. & Wedgwood R. J. P. The primary immunodeficiencies. New England Journal of Medicine, 1995, 333, 431.
88. Spitz M. R., Hoque A., Trizna Z., Schantz S. P., Amos C. I., King T. M., Bondy M. L., Hong W. K. & Hsu T. C. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. Journal of the National Cancer Institute, 1994, 86, 1681.
89. Siegel M. Smoking and leukemia: evaluation of a causal hypothesis. American Journal of Epidemiology, 1993, 138, 1.
90. Crawford F. G., Mayer J., Santella R. M., Cooper T. B., Ottman R., Tsai W. Y., Simon-Cereijido G., Wang M., Tang D. & Perera F. P. Biomarkers of environmental tobacco smoke in preschool children and their mothers. Journal of the National Cancer Institute, 1994, 86, 1398.
91. Schut H. A. J. & Shiverick K. T. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. Federation of American Societies for Experimental Biology, 1992, 6, 2942.
92. McMichael A. J. "Molecular epidemiology": new pathway or new travelling companion? American Journal of Epidemiology, 1994, 140, 1.
93. Wiencke J. K., Kelsey K. T., Varkonyi A., Semey K., Wain J. C., Mark E. & Christiani D. C. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Research, 1995, 55, 4910.
94. Hollstein M., Sidransky D., Vogelstein B. & Harris C. C. p53 mutations in human cancers. Science, 1991, 253, 49.
95. Smith M. A., Rubinstein L. & Ungerleider R. S. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks. Medical Pediatrics and Oncology, 1994, 23, 86.
96. Canaani E., Nowell P. C. & Croce C. M. Molecular genetics of 11q23 chromosome translocations. Advances in Cancer Research, 1995, 66, 213.
97. Domer P. H., Head D. R., Renganathan N., Raimondi S. C., Yang E. & Atlas M. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia, 1995, 9, 1305.
98. Abdallah J. M., Lombardi D. P. & Kirsch I. R. Genetic instability in patients with Hodgkin's disease undergoing chemotherapy. Journal of Clinical Investigations, 1995, 96, 2744.
99. Tales A. D., van Dam F. J., Natarajan A. T., Zwinderman A. H. & Osanto S. Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study. Mutation Research, 1994, 307, 293.
100. Mott M. G., Boyse J., Hewitt M. & Radford M. Do mutations at the glycophorine A locus in patients treated for childhood Hodgkin's disease predict secondary leukemia? Lancet, 1994, 343, 828.
101. Mitelman F., Mark J., Levan G. & Levan A. Tumor etiology and chromosome pattern. Science, 1972, 176, 1340.
102. Rowley J. D. Do human tumors show a chromosome pattern specific for each etiologic agent? Journal of the National Cancer Institute, 1974, 52, 315.
103. Sugiyama T., Kurita Y. & Nishizuka Y. Chromosome abnormality in rat leukemia induced by 7,12-dimethylbenz[a]anthracene. Science, 1967, 158, 1058.
104. Rees E. D., Majumdar S. K. & Shuck A. Changes in chromosomes of bone marrow after intravenous injections of 7,12-dimethylbenz[a]anthracene and related compounds. Proceedings of the National Academy of Sciences, U.S.A., 1970, 66, 1228.
105. Sugiyama T. Specific vulnerability of the largest telocentric chromosome of rat bone marrow cells to 7,12-dimethylbenz[a]anthracene. Journal of the National Cancer Institute, 1971, 47, 1267.
106. Bishop J. M. The molecular genetics of cancer. Science, 1987, 235, 305.
107. Larson R. A., Sandler D. P. & Le Beau M. M. Acute leukemia: biology and treatment. Hematology 1994. Education Program American Society of Hematology, 1994, 34.
108. Linet M. S., McLaughlin J. K., Malker H. S. R., Chow W. H., Weiner J. A., Stone B. J., Ericsson J. L. E. & Fraumeni J. F. Occupation and hematopoietic and lymphoproliferative malignancies among women: A linked registry study. JOM, 1994, 36, 1187.
109. Sandler D. P. Recent studies in leukemia epidemiology. Current Opinions in Oncology, 1995, 7, 12.
110. Matanoski G. M., Elliott E. A., Breysse P. N. & Lyndberg M. C. Leukemia in telephone linemen. American Journal of Epidemiology, 1993, 137, 609.
111. Sahl J. D., Kelsh M. A. & Greenland S. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology, 1993, 4, 104.
112. Tynes T., Jynge H. & Vistnes A. I. Leukemia and brain tumors in Norwegian railway workers. a nested case-control study. American Journal of Epidemiological, 1994, 139, 645.
113. Rodella S. R., Ciccone G., Rege-Cambrin J. & Vineis P., Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy: Cytogenetics and occupational exposures in acute nonlymphocytic leukemia and myelodysplastic syndrome. Scandinavian Journal of Work Environmental Health 19, 369.
114. Mitelman F., Brandt L. & Nilsson P. G. Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood, 1978, 52, 1229.
115. Mitelman F., Nilsson P. G., Brandt L., Alimena G., Gastaldi R. & Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 1981, 4, 197.
116. Lawler S. D., Summersgill B. M., Clink H. Me. D. & McElwain T. J. Chromosomes, leukaemia, and occupational exposure to leukaemogenic agents. Lancet, 1979, 2, 853.
117. Mitelman F., Nilsson P. G. & Brandt L. Fourth international workshop on chromosomes in leukemia, 1982: The correlation of karyotype and occupational exposure to potential mutagenic/carcinogenic agents in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 1984, 11, 326.
118. Vineis P., Avanzi G. C., Giovinazzo B., Ponzio G., Cambrin G. R. & Ciccone G. Cytogenetic and occupational exposure to solvents: A pilot study of leukemias and myelodysplastic disorders. Tumori, 1990, 76, 350.
119. Crane M. M., Keating M. J., Trujillo J. M., Labarthe D. R. & Frankowski R. F. Environmental exposures in cytogenetically defined subsets of acute nonlymphocytic leukemia. Journal of the American Medical Association, 1989, 262, 634.
120. Sandler D. P., Shore D. L., Anderson J. R., Davey F. R., Arthur D., Mayer R. J., Silver R. T., Weiss R. B., Moore J. O., Schiffer C. A., Wurster-Hill D. H., McIntyre O. R. & Bloomfield C. D. Cigarette smoking and risk of acute leukemia: Associations with morphology and cytogenetic abnormalities in bone marrow. Journal of the National Cancer Institute, 1993, 85, 1994.
121. Sawyers C. L., Denny C. T. & Witte O. N. Leukemia and the disruption of normal hematopoiesis. Cell, 1991, 64, 337.
122. Varmus H. E. & Lowell C. A. Cancer genes and hematopoiesis. Blood, 1994, 83, 5.
123. Porfiri E., Seeker-Walker L. M., Hoffbrand A. V. & Hancock J. F. DCC tumor suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood, 1993, 81, 2696.
124. Porfiri E. DCC (Deleted in Colorectal Cancer) inactivation in hematological malignancies. Leukemia and Lymphoma, 1995, 180, 69.
125. Liu E., Hjelle B., Morgan R., Hecht F. & Bishop J. M. Mutations of the Kirsten-ras proto-oncogene in human preleukaemia. Nature, 1987, 330, 186.
126. Liu E. T. The role of ras gene mutations in myeloproliferative disorders. Clinical Laboratory Medicine, 1990, 10, 797.
127. Needleman S. W. ras protooncogene activation in acute myeloid leukemia and related disorders. Leukemia and Lymphoma, 1991, 5, 85.
128. Taylor J. A., Sandler D. P., Bloomfield C. D., Shore D. L., Ball E. D., Neubauer A., McIntyre O. R. & Liu E. ras oncogene activation and occupational exposures in acute myeloid leukemia. Journal of the National Cancer Institute, 1992, 84, 1626.
129. Smith M. T., Wiemels J., Rothman N. & Linet M. Chemical exposure, ras oncogene activation, and acute myeloid leukemia. Journal of the National Cancer Institute, 1992, 84, 1614.
130. Sbrana I. & Musio A. Enhanced expression of common fragile site with occupational exposure to pesticides. Cancer Genetics and Cytogenetics, 1995, 82, 123.
131. Yunis J. J. The chromosomal basis of human neoplasia. Science, 1983, 221, 227.
132. Brown L. M, Blair A., Gibson R., Everett G. D., Cantor K. P., Schuman L. M., Burmeister L. F., Van Lier S. F. & Dick F. Pesticide exposures and other agricultural risk factors for leukemia among men in Iowa and Minnesota. Cancer Research, 1990, 50, 6585.
133. Cantor K. P., Blair A., Everett G., Gibson R., Burmeister L. F., Brown L. M., Schuman L. & Dick F. R. Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota. Cancer Research, 1992, 52, 2447.
134. Mules E. H., Testa J. R., Thomas G. H., Abbey H. & Cohen B. H. Cancer in relatives of leukemic patients with chromosomal rearrangements at rare (heritable) fragile-site locations in their malignant cells. American Journal of Human Genetics, 1989, 44, 811.
135. Bloomfield C. D., Arthur D. C., Frizzera G., Levine E. G., Peterson B. A. & Gajl-Peczalska K. J. Nonrandom chromosome abnormalities in lymphoma. Cancer Research, 1983, 43, 2975.
136. Fifth international workshop on chromosomes in leukemia-lymphoma. Correlation of chromosome abnormalities with histologie and immunologic characteristics of non-Hodgkin's lymphoma and adult T cell leukemia-lymphoma. Blood, 1987, 70, 1554.
137. Levine E. & Bloomfield C. Cytogenetics of non-Hodgkin's lymphoma. Journal of the National Cancer Institute Monographs, 1990, 10, 7.
138. Brandt L., Kristoffersson U., Olsson H. & Mitelman F. Relation between occupational exposure to organic solvents and chromosome aberrations in non-Hodgkin's lymphoma. European Journal of Haematology, 1989, 42, 298.
139. Hoar S. K., Blair A., Holmes F. F., Boysen C. D., Robel R. J., Hoover R. & Fraumeni J. F. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. Journal of the American Medical Association, 1986, 256, 1141.
140. Zahm S. H., Weisenburger D. D., Babbitt P. A., Saal R. C., Vaught J. B., Cantor K. P. & Blair A. A case control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D in Eastern Nebraska. Epidemiology, 1990, 1, 349.
141. Lipkowitz S., Garry V. F. & Kirsch I. R. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proceedings of the National Academy of Sciences, U.S.A., 1992, 89, 5301.
142. Garry V. F., Tarone R. E., Long L., Griffith J., Kelly J. T & Burroughs B. Pesticide appliers with mixed pesticide exposure: G-banded analysis and possible relationship to non-Hodgkin's lymphoma. Cancer Epidemiology Biomarkers Preview, 1996, 5, 11.
143. Pottern L. M., Linet M., Blair A., Dick F., Burmeister L F., Gibson R., Schuman L. M. & Fraumeni J. F. Jr Familial cancers associated with subtypes of leukemia and non-Hodgkin's lymphoma. Leukemia Research, 1991, 15, 305.
144. Magrath I. Molecular basis of lymphomagenesis. Cancer Research, 1992, 52, 5529s (Suppl.).
145. Osmond D. G., Priddle S. & Rico-Vargas S. Proliferation of B-cell precursors in bone marrow of pristane-conditioned and malaria-infected mice: implications for B-cell oncogenesis. Current Topics in Microbiology and Immunology, 1990, 166, 149.
146. Borden E. C, Waalen J., Liberati A. M. & Grignani F. Molecular diagnosis and monitoring of leukemia and lymphoma. Leukemia Research, 1993, 17, 1073.
147. First MIC cooperative study group: Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias Cancer Genetics and Cytogenetics, 1986, 23, 189.
148. Second MIC cooperative study group: Morphologic, immunologic, and cytogenetic (MIC) working classification of acute myeloid leukemias Cancer Genetics and Cytogenetics, 1988, 30, 1.
149. Catovsky D. The molecular classification of leukaemias and lymphomas. Leukemia, 1995, 9, 1421.
150. Eikelboom J., Cull G. & Erber W. Time for a new acute myeloid leukaemia classification? British Journal of Haematology, 1996, 92, 247.
151. Pui C. H. Childhood leukemias. New England Journal of Medicine, 1995, 332, 1618.
152. Roberts W. M., Rivera G. K., Raimondi S. C., Santana V. M., Sandlund J. T., Crist W. M. & Pui C. H. Intensive chemotherapy for Phildelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet, 1994, 343, 331.
153. Ben-Bassat I., Bandini G., Rosti G. & Gale R. P. Are we curing acute myelogenous leukemia? Leukemia Research, 1993, 17, 1071.
154. Kuller L. H., Traven N. D., Rutan G. H., Perper J. A. & Ives D. G. Marked decline of coronary heart disease mortality in 35-44-year-old white men in Allegheny County Pennsylvania. Circulation, 1989, 80, 261.
155. Boguski M. S. Hunting for genes in computer data bases. New England Journal of Medicine, 1995, 333, 645.
156. Perera F. Biomarkers and molecular epidemiology of occupationally related cancer. Journal of Toxicology and Environmental Health, 1993, 40, 203.
157. Karp J. E. & McCaffrey R. P. New avenues of translational research in leukemia and lymphoma: Outgrowth of a Leukemia Society of America - National Cancer Institute Workshop. Journal of the National Cancer Institute, 1994, 86, 196.
158. Dorman J. S., Trucco M., LaPorte R. E. & Kuller L. H. Family studies: the key to understanding the genetic and environmental etiology of chronic disease? Genetics and Epidemiology, 1988, 5, 305.
159. Birrer M. J. Translational research and epithelial carcinogenesis: molecular diagnostic assays now - molecular screening assays soon? Journal of the National Cancer Institute, 1995, 87, 1041.
160. Jacobson D. R. & Mills N. E. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene, 1994, 9, 553.
161. Izraeli S. & Lion T. Multiprimer-PCR for screening of genetic abnormalities in acute lymphoblastic leukaemia. British Journal of Haematology, 1991, 79, 645.
162. Izraeli S., Janssen J. W. G., Haas O. A., Harbott J., Brok-Simoni F., Walther J. U., Kovar H., Henn T., Ludwig W. D., Reiter A., Rechavi G., Bartram C. R., Gadner H. & Lion T. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparision between cytogenetic and polymerase chain reaction analyses. Leukemia, 1993, 7, 671.
163. Repp R., Borkhardt A., Haupt E., Kreuder J., Brettreich S., Hammermann J., Nishida K., Harbott J. & Lampert F. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluoresence-based automatic DNA-fragment analysis. Leukemia, 1995, 9, 210.
164. Borkhardt A., Haas O. A., Harbott J., Hammermann J., Repp R., Kreuder J., Mitteis M. & Lampert F. Detection of 11Q23/MLL abnormalities in childhood acute leukemias by multiplex RT - PCR. Blood, 1995, 86, (Suppl 1, abstr. 132).
165. Seminara D. & Obrams I. Genetic epidemiology of cancer: a multidisciplinary approach. Genetics and Epidemiology, 1994, 11, 235.
166. Henderson B. E., ROSS R. K. & Pike M. C. Toward the primary prevention of cancer. Science, 1991, 254, 1131.
167. Reizenstein P., Modan B. & Kuller L. H. The quandary of cancer prevention. Journal of Clinical Epidemiology, 1994, 47, 575.